Start Of In-Patient Clinical Trials With NT-KO-003, The First Neuroprotective Drug For Multiple Sclerosis Without Immunosuppressive Effects
BARCELONA, July 19, 2011 /PRNewswire/ --
- NT-KO-003, developed by Advancell and Neurotec Pharma, is the first MS drug with neuroprotective effects that does not cause immunosuppression.
- This…